• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20年间通过常规实验室检查值得出的囚犯丙型肝炎感染发病率。

Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.

作者信息

Marco Andrés, Gallego Carlos, Caylà Joan A

机构信息

Health Services of Barcelona Men's Penitentiary Centre, Barcelona, Department of Justice, Government of Catalonia, Barcelona, Spain.

Health Services of Quatre Camins Penitentiary Centre, La Roca del Vallés, Barcelona, Department of Justice, Government of Catalonia, Barcelona, Spain.

出版信息

PLoS One. 2014 Feb 28;9(2):e90560. doi: 10.1371/journal.pone.0090560. eCollection 2014.

DOI:10.1371/journal.pone.0090560
PMID:24587394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3938777/
Abstract

BACKGROUND

To estimate the incidence of Hepatitis C virus (HCV) and the predictive factors through repeated routine laboratory analyses.

METHODS

An observational cohort study was carried out in Quatre Camins Prison, Barcelona. The study included subjects with an initial negative HCV result and routine laboratory analyses containing HCV serology from 1992 to 2011. The incidence of infection was calculated for the study population and for sub-groups by 100 person-years of follow-up (100 py). The predictive factors were determined through Kaplan-Meier curves and a Cox regression. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated.

RESULTS

A total of 2,377 prisoners were included with a median follow-up time of 1,540.9 days per patient. Among the total population, 117 HCV seroconversions were detected (incidence of 1.17/100 py). The incidence was higher between 1992 and 1995 (2.57/100 py), among cases with HIV co-infection (8.34/100 py) and among intravenous drug users (IDU) without methadone treatment (MT) during follow-up (6.66/100 py). The incidence rate of HCV seroconversion among cases with a history of IDU and current MT was 1.35/100 py, which is close to that of the total study population. The following variables had a positive predictive value for HCV infection: IDU (p<0.001; HR = 7,30; CI: 4.83-11.04), Spanish ethnicity (p = 0.009; HR = 2,03; CI: 1.93-3.44) and HIV infection (p = 0.015; HR = 1.97; CI: 1.14-3.39).

CONCLUSION

The incidence of HCV infection among prisoners was higher during the first part of the study and among IDU during the entire study period. Preventative programs should be directed toward this sub-group of the prison population.

摘要

背景

通过重复的常规实验室分析评估丙型肝炎病毒(HCV)的发病率及预测因素。

方法

在巴塞罗那的夸特卡明斯监狱开展了一项观察性队列研究。该研究纳入了HCV初筛结果为阴性且在1992年至2011年期间进行过包含HCV血清学检测的常规实验室分析的受试者。通过每100人年随访(100 py)计算研究人群及亚组的感染发病率。通过Kaplan-Meier曲线和Cox回归确定预测因素。计算风险比(HR)和95%置信区间(CI)。

结果

共纳入2377名囚犯,每位患者的中位随访时间为1540.9天。在总人口中,检测到117例HCV血清学转换(发病率为1.17/100 py)。1992年至1995年期间发病率较高(2.57/100 py),在合并感染HIV的病例中(8.34/100 py)以及在随访期间未接受美沙酮治疗(MT)的静脉吸毒者(IDU)中(6.66/100 py)发病率较高。有IDU病史且目前接受MT治疗的病例中HCV血清学转换的发病率为1.35/100 py,与整个研究人群的发病率相近。以下变量对HCV感染具有阳性预测价值:IDU(p<0.001;HR = 7.30;CI:4.83 - 11.04)、西班牙裔(p = 0.009;HR = 2.03;CI:1.93 - 3.44)和HIV感染(p = 0.015;HR = 1.97;CI:1.14 - 3.39)。

结论

在研究的第一阶段囚犯中HCV感染发病率较高,在整个研究期间IDU中发病率较高。预防项目应针对监狱人群中的这一亚组。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/f19081b15864/pone.0090560.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/dd2533ab16e1/pone.0090560.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/e6d1f6fd6b31/pone.0090560.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/a0eda883f7c9/pone.0090560.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/f19081b15864/pone.0090560.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/dd2533ab16e1/pone.0090560.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/e6d1f6fd6b31/pone.0090560.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/a0eda883f7c9/pone.0090560.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4f/3938777/f19081b15864/pone.0090560.g004.jpg

相似文献

1
Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.20年间通过常规实验室检查值得出的囚犯丙型肝炎感染发病率。
PLoS One. 2014 Feb 28;9(2):e90560. doi: 10.1371/journal.pone.0090560. eCollection 2014.
2
Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002-2016.2002-2016 年在西班牙加泰罗尼亚地区,对慢性丙型肝炎进行治疗后具有持续病毒学应答的大量囚犯队列中的再感染。
Int J Drug Policy. 2019 Oct;72:189-194. doi: 10.1016/j.drugpo.2019.05.014. Epub 2019 May 31.
3
[Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison].[西班牙一所监狱中囚犯感染艾滋病毒、丙型肝炎病毒及合并感染的预测标志物]
Enferm Infecc Microbiol Clin. 2005 Feb;23(2):53-7. doi: 10.1157/13071605.
4
Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.2004 - 2011年西班牙多中心HIV阳性患者队列中丙型肝炎病毒(HCV)的发病率:HCV诊断率上升,但HCV血清转化发生率未上升。
PLoS One. 2014 Dec 30;9(12):e116226. doi: 10.1371/journal.pone.0116226. eCollection 2014.
5
The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.2017 年爱尔兰男性囚犯中未经治疗的慢性丙型肝炎病毒(HCV)感染的血清流行率及其相关危险因素:一项横断面研究。
Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.
6
Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.南澳大利亚囚犯中的丙型肝炎病毒感染:血清流行率、血清转化及危险因素。
Int J Infect Dis. 2009 Mar;13(2):201-8. doi: 10.1016/j.ijid.2008.06.011. Epub 2008 Sep 13.
7
Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.一大群注射毒品囚犯中丙型肝炎病毒感染的发病率及其相关因素。
BMC Public Health. 2014 Aug 11;14:830. doi: 10.1186/1471-2458-14-830.
8
A prospective study of hepatitis C incidence in Australian prisoners.澳大利亚囚犯丙型肝炎发病率的前瞻性研究。
Addiction. 2014 Oct;109(10):1695-706. doi: 10.1111/add.12643. Epub 2014 Jul 15.
9
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.瑞士艾滋病毒队列研究中的丙型肝炎病毒感染:一种迅速演变的流行疾病。
Clin Infect Dis. 2012 Nov 15;55(10):1408-16. doi: 10.1093/cid/cis694. Epub 2012 Aug 14.
10
Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.接受阿片类药物替代疗法的注射吸毒者中丙型肝炎病毒的发病率。
Aust N Z J Public Health. 2004 Dec;28(6):576-8. doi: 10.1111/j.1467-842x.2004.tb00050.x.

引用本文的文献

1
How to eliminate hepatitis C between people who inject drugs in community services and prisons in Catalonia.如何在加泰罗尼亚的社区服务机构和监狱中,消除注射吸毒者之间的丙型肝炎传播。
Harm Reduct J. 2025 Jul 31;22(1):133. doi: 10.1186/s12954-025-01286-w.
2
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.监狱环境中丙型肝炎病毒感染的发生率:SToP-C 研究。
J Viral Hepat. 2024 Jan;31(1):21-34. doi: 10.1111/jvh.13895. Epub 2023 Nov 7.
3
Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.

本文引用的文献

1
Chronic hepatitis C virus (HCV) disease burden and cost in the United States.美国慢性丙型肝炎病毒(HCV)疾病负担和成本。
Hepatology. 2013 Jun;57(6):2164-70. doi: 10.1002/hep.26218. Epub 2013 May 6.
2
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection.意大利南部地方性流行区丙型肝炎病毒感染 14 年后:感染正在消失的证据。
Dig Liver Dis. 2013 May;45(5):403-7. doi: 10.1016/j.dld.2012.10.014. Epub 2012 Nov 28.
3
[Evolution of the need and coverage of syringe exchange programs in Spanish prisons, 1992-2009: A revised estimation].
2013-2021 年监禁环境中丙型肝炎流行率:系统评价和荟萃分析。
BMC Public Health. 2022 Nov 24;22(1):2159. doi: 10.1186/s12889-022-14623-6.
4
The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.全球和区域范围内,合并感染 HIV 的囚犯中丙型肝炎和乙型肝炎的流行情况:系统评价和荟萃分析。
Infect Dis Poverty. 2021 Jul 1;10(1):93. doi: 10.1186/s40249-021-00876-7.
5
New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019.2019年爱尔兰男性囚犯中的新型丙型肝炎病毒感染、再感染及相关风险行为:一项队列研究
Arch Public Health. 2021 Jun 8;79(1):97. doi: 10.1186/s13690-021-00623-2.
6
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.在监狱中关押人群中消除丙型肝炎:在卫生系统框架内采取行动的挑战和建议。
Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400. doi: 10.1016/S2468-1253(20)30365-4.
7
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.药物治疗阿片类药物使用障碍对监禁人群丙型肝炎发病率的影响:系统评价。
Infect Dis Clin North Am. 2020 Sep;34(3):559-584. doi: 10.1016/j.idc.2020.06.011.
8
Cost-effectiveness analysis of chronic hepatitis C treatment in the prison population in Spain.西班牙监狱人群慢性丙型肝炎治疗的成本效益分析。
Rev Esp Sanid Penit. 2020 May-Aug;22(2):66-74. doi: 10.18176/resp.00012. Epub 2020 Jul 20.
9
Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky.在肯塔基州农村地区,对监禁在 HCV 传播和预防中的作用进行建模。
Int J Drug Policy. 2021 Feb;88:102707. doi: 10.1016/j.drugpo.2020.102707. Epub 2020 Mar 6.
10
Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.欧盟/欧洲经济区具有多重风险因素的重点人群中乙型和丙型肝炎的流行率和发病率:系统评价。
Euro Surveill. 2019 Jul;24(30). doi: 10.2807/1560-7917.ES.2019.24.30.1800614.
[1992 - 2009年西班牙监狱注射器交换项目的需求与覆盖情况演变:一项修订后的评估]
Rev Esp Sanid Penit. 2012 Feb;14(3):86-90. doi: 10.4321/S1575-06202012000300003.
4
Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis.血液透析患者丙型肝炎病毒感染的发生率:一项系统评价和荟萃分析。
Hemodial Int. 2013 Oct;17(4):532-41. doi: 10.1111/j.1542-4758.2012.00761.x. Epub 2012 Oct 16.
5
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis.阿片类物质替代治疗与注射吸毒人群中 HIV 的传播:系统评价和荟萃分析。
BMJ. 2012 Oct 3;345:e5945. doi: 10.1136/bmj.e5945.
6
HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China.中国长沙和武汉美沙酮维持治疗(MMT)门诊和非 MMT 门诊海洛因成瘾者中丙型肝炎病毒和人类免疫缺陷病毒感染。
PLoS One. 2012;7(9):e45632. doi: 10.1371/journal.pone.0045632. Epub 2012 Sep 21.
7
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.在苏格兰提供无菌注射设备的场所接受注射吸毒者中,减少伤害干预措施的采用与近期丙型肝炎感染之间的关联。
Int J Drug Policy. 2012 Sep;23(5):346-52. doi: 10.1016/j.drugpo.2012.07.006. Epub 2012 Aug 31.
8
The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.雪松项目:在加拿大两个城市对使用毒品的年轻原住民进行的纵向研究中,丙型肝炎病毒感染发病率很高。
BMC Public Health. 2012 Aug 9;12:632. doi: 10.1186/1471-2458-12-632.
9
Evolving epidemiology of hepatitis C virus in the United States.美国丙型肝炎病毒流行趋势的演变。
Clin Infect Dis. 2012 Jul;55 Suppl 1(Suppl 1):S3-9. doi: 10.1093/cid/cis393.
10
HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.基线时从未注射过海洛因的吸毒者中 HCV 血清转换:除开始注射外,未发现其他预测因素。
Int J Drug Policy. 2012 Sep;23(5):415-9. doi: 10.1016/j.drugpo.2012.02.002. Epub 2012 Mar 14.